Security key
G1933S101
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 100
- Total 13F value
- $179
- Share change
- +100
- SEC-reported price per share
- $1.79
- Number of holders
- 1
- Value change
- +$179
- Number of buys
- 1
- Shares outstanding
- 40,791,726
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
1
Top holders
1
CASIF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
CASI Pharmaceuticals, Inc. SEC filings
CASI Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G1933S101
Recent filing periods:
Ownership snapshot
Top reported holders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FEDERATED HERMES, INC.
Disclosed value leader
FEDERATED HERMES, INC.
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F
Highest disclosed value: $2,639,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FEDERATED HERMES, INC. has the largest disclosed position value at $2.64M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FEDERATED HERMES, INC.'s linked filing trail.
Disclosed position value
Top 5
FEDERATED HERMES, INC.
$2.64M
VANGUARD GROUP INC
$669K
Wellington Shields Capital Manage...
$567K
Wellington Shields & Co., LLC
$378K
GEODE CAPITAL MANAGEMENT, LLC
$255K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
Company
|
—
class O/S missing
|
$2,639,000
1,015,000 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$669,000
257,443 shares
|
— | 30 Sep 2022 |
| Wellington Shields Capital Management, LLC |
13F
Company
|
—
class O/S missing
|
$567,000
218,247 shares
|
— | 30 Sep 2022 |
| Wellington Shields & Co., LLC |
13F
Company
|
—
class O/S missing
|
$378,000
145,315 shares
|
— | 30 Sep 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$255,000
98,308 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$239,000
91,714 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
100
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q4 2025 Across Filers
Q4 2025 holders
16
Q4 2022 holders
1
Holder diff
-15
| Investor | Q4 2025 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend